Table 1. . The miRNAs carried by tumor-derived exosomes and delivered to immune cells induce protumorigenic functions.
miRNA carried by TEX | Tumor type | Recipient cell | Acquired functions | Consequences for recipient cells |
---|---|---|---|---|
miR-21 miR-29a | NSLC | TAMs | NF-κB pathway | |
IL-6, TNF-α | Proinflammatory phenotype | |||
miR-203 miR-212p |
PAC | DCs |
TLR-4 TNF-α, IL-12 |
DC maturation DC dysfunction |
miR-214 | Various human or mouse tumors | T cells |
Treg PTEN IL-10 |
Immune suppression |
miR-183 | Human tumor cell lines | NK cells |
TGF-β DAP12 |
Lytic functions |
miR-92a | Glioma | NKT cells |
Perforin FasL IFN-γ CD8+ T cells |
Tumor apoptosisAntitumor activity |
Selected examples of miRNA interactions with different types of immune cells are presented. For a detailed review of TEX-associated miRNAs and their biological effects, see [34].
DC: Dendritic cell; NK: Natural killer; NSLC: Non-small-cell lung cancer; PAC: Pancreatic adenocarcinoma; TAM: Tumor-associated macrophage; TEX: Tumor-derived exosome.